Share Name Share Symbol Market Type Share ISIN Share Description
Cineworld LSE:CINE London Ordinary Share GB00B15FWH70 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 545.00p 543.50p 545.00p 545.00p 538.00p 539.00p 303,352.00 16:29:55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Travel & Leisure 705.8 99.7 30.7 17.8 1,455.98

Cineworld (CINE) Latest News (1)

More Cineworld News
Cineworld Takeover Rumours

Cineworld (CINE) Share Charts

1 Year Cineworld Chart

1 Year Cineworld Chart

1 Month Cineworld Chart

1 Month Cineworld Chart

Intraday Cineworld Chart

Intraday Cineworld Chart

Cineworld (CINE) Discussions and Chat

Cineworld Forums and Chat

Date Time Title Posts
04/12/201616:51CINEWORLD1,566.00
19/11/201414:16Cineworld (CINE) - IMS-
27/10/200918:37CINE: 165p resistance..2.00
13/2/200900:04Cineworld (LSE:CINE) into administration?1.00
04/7/200707:51welcome to the cinema3.00

Add a New Thread

Cineworld (CINE) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Cineworld trades in real-time

Cineworld (CINE) Top Chat Posts

DateSubject
04/12/2016
08:20
Cineworld Daily Update: Cineworld is listed in the Travel & Leisure sector of the London Stock Exchange with ticker CINE. The last closing price for Cineworld was 545p.
Cineworld has a 4 week average price of 543.70p and a 12 week average price of 557.03p.
The 1 year high share price is 618p while the 1 year low share price is currently 454.70p.
There are currently 267,151,737 shares in issue and the average daily traded volume is 246,436 shares. The market capitalisation of Cineworld is £1,455,976,966.65.
23/4/2016
01:57
lauders: Mixed messages here! The last RNS states in increase in institutional holdings (over 5%), the Sheffield presentation looked good to me (see below & the progress with refurbishments & the Starbucks alliance that seems to be gaining traction), yet the share price is showing weakness. Hope that a few broker notes that reflect the progress are issued next week or soon! Http://www.cineworldplc.com/~/media/Files/C/Cineworld-PLC/reports-and-presentations/2016-analyst-day.pdf
19/3/2016
01:43
lauders: Seems CINE was upgraded by Canaccord Genuity to a target of 520p from 500p yesterday. Wow! Big target that has already been surpassed. They increase based on: ".... increasing the chain's fiscal 2016 EPS forecast 5.0% to 31.3p and 2017's by 6.8% to 33.9p and is introducing a 2018 forecast of 37.1p. Says the growth is mostly driven by a lower tax charge and the rollout of new multiplexes rather than any material improvement in trading." They retain a "hold rating", which usually means sell in broker jargon! Helped with the share price today but will hopefully go much higher and smash their already beaten "target". Brokers! Not worth the time from experience.
16/3/2016
01:37
lauders: Nice to see a mini-recovery here to above 500p. Cannot believe the impact the DB downgrade had on the share price before results and the slow recovery post positive results + an upgrade. Hopefully we will be back on the way up to 600p over the next month or so.
10/3/2016
12:52
soundbuy: Cazenove. Cineworld had what we regard as a very strong year in 2015. EBITDA was up 18.5% on a proforma basis to £155m, 1% above our estimate. A record 18 new sites were opened across the estate. 2016 has started well, especially in CEE and Israel, but the UK has also been solid and in line with expectations. Our EPS estimates increase by 3% in both FY16 and FY17. We remain Overweight with an increased price target of 610p, March 2017 (was 600p to Dec-16).  Solid headline performance. Revenue was up 13.9% (12.4% proforma) to £706m, in line with our estimate of £707m. EBITDA was £155.3m, 1% above our estimate of £154.2m. Adjusted PBT was £102.8m, up 37% and above our estimate of £94.1m and Bloomberg consensus of £96.2m due mainly to a lower depreciation charge. Adjusted EPS was 31.7p, which was above our estimate of 27.9p and Bloomberg consensus of 28.3p due to lower depreciation and a lower effective tax rate.  Margin expansion. As well as increasing overall admissions by 6.5%, Cineworld achieved growth in average ticket prices and retail spend per person. This, coupled with operating cost efficiencies, allowed the EBITDA margin to expand from 20.4% to 22.0%.  Outlook is positive. We believe the outlook for further growth in 2016 is very positive. We expect a further 13 new sites to be opened (6 in the UK and 7 in CEE/Israel). We also believe that Cineworld's business model will see it outperform the UK box office in 2016.  Changes to earnings estimates. There are no material changes to our adjusted EBITDA estimates, which remain £170m in FY16 and £185m in FY17. The assumption of a lower depreciation charge means our operating profit estimates increase by 3% from £114.1m to £117.4m in FY16 and by 2% from £125.3m to £128.4m in FY17. Our adjusted EPS estimates increase by 3% from 32.3p to 33.2p in FY16 and by 3% from 35.4p to 36.4p in FY17. Canaccord. Cineworld's FY15 results were slightly ahead of consensus driven by the UK Other line which includes film advertising. But we believe it could have been so much better. Cineworld lost UK box office market share in FY15 and we estimate that it could be missing out on as much as £2.2m of additional EBITDA per blockbuster in the UK. Assuming a blockbuster/quarter that puts Cineworld’s missed UK opportunity at £8.8m. For Bond, Hunger Games and Star Wars, the scale of the missed opportunity could have been as much as £6.6m. The FY16 film slate is weaker and we do not expect consensus to change materially. We retain our HOLD recommendation as the share price is below our target price. Detail Cineworld reported FY15 EBITDA of £155.3m (+22.7%) and Adj PBT of £102.8m (+37.15) with both reporting divisions performing equally well. To put performance into context, Cineworld lost UK market share with box office revenue +8.0% versus market +17.4%. Q1 has been saved by Deadpool, but the film slate is weaker this year with the mix to more family films and less blockbusters, no material change to consensus is expected at this stage. The openings programme is on track: 18 new cinemas opened in FY15 and Cineworld will continue to open 13-14 new multiplexes per annum from now on. The dividend was +30% to 17.5p and net debt/EBITDA reduced by £37m to £282m. Cineworld can fund all requirements from cashflow. Cineworld has appointed Mr Dean Moore as interim CFO for 12 months pending the promotion of Nissan Cohen to the job, who becomes deputy CFO. Valuation Yesterday's closing share price of 480p values the stock on a P/E of 16.1x for FY16E and 15.1x for FY17E, and EV/EBITDA of 8.9x falling to 8.2x, and FCF yield of 9.2% rising to 9.9%. Our 500p share price target is based on a PE of 16.8x, an EV/EBITDA of 9.2x and 8.8% FCF for FY16E. The default Quest® valuation is 302p. The stock has performed relatively well compared to IMAX and Cineplex. Our CG preferred stock remains IMAX (IMAX : NYSE : US$32 | BUY, TP: US$37).
05/3/2016
02:40
lauders: Thanks SoundBuy! Not sure why brokers can't wait until AFTER results to issue such notes? They would surely have more "facts" to use than predicting beforehand? Looks like the price was rising "for no apparent reason" and UBS took advantage of that to knock them back a bit. The cynic in me would say this was done so one of their clients could load-up before results, but what do I know? They may well be turning around and issuing a buy note next week and then the share price will hardly move. Quite amazing how the market works sometimes. leadersoffice - Very astute investment advice LOL! Perhaps you should provide a bit more substance than that, looks rather weak and rampy IMO. To their credit UBS do hit on an interesting point and that is the demographics of CEE countries may be changing and this might have an effect. Not sure about the children's films point. The CEE have their own productions and not sure how many are children focused ones. The point about lower admission fees in the UK is also interesting, but surely that would attract MORE people and thereby keep their premises busier than their competitors? Arguments for and against as usual! The other side of the coin and more positive opinions: Http://www.emqtv.com/numis-securities-ltd-reaffirms-add-rating-for-cineworld-group-plc-cine/218026/ Numis was the most recent with "add" before UBS came along to spoil the "party"! All will be revealed on 10th March when results are released!
31/10/2015
12:39
lauders: Well this is confusing! Below are both notes from the same "broker" a week apart. Nothing like confusing your clients! Perhaps one client liked the original one so much and agreed so much they convinced Canaccord to issue another contrary one so they could load-up! Surely the FSA should look into obvious cases like this? Seems crazy! Canaccord has latched onto Bond-mania with the release of Sceptre, the latest film in the long-running franchise, on Monday to repeat its ‘buy’ rating on cinema chain Cineworld (LON;CINE). But it is the less racy expansion opportunity for the chain in eastern Europe that has got the broker’s juices running. An analysts’ trip to Romania confirmed the commanding position in a growing market held by Cineworld in a country where there is little competition said the broker. Subsidiary Cinema City operates 21 of 34 multiplexes in Romania with plans to take it to 40 multiplexes in the next five years. Cineworld also makes more money per pound of investment in Romania that anywhere else. The 40 multiplex target is realistic, believes Canaccord, as Romania has a population of 20mln and there are 23 cities with a population of over 100,000. James Bond and Star Wars excitement meanwhile has led to problems coping with the demand. Canaccord said Cineworld had confirmed its website had crashed along with its rivals due to the surge of interest, with as many ticket requests for Star Wars in a day as normally come in over three months. Buy with a 620p target price says the broker. Cannacorde note....We are reducing our Cineworld recommendation to SELL from Buy with a new, lowered share price target of 535p (from 620p), implying c10% downside. It’s time to take profits. Cineworld’s share price is up 75% over the last 12 months driven in large part by this year’s fantastic film slate that climaxes this quarter with three blockbusters: Bond Spectre, Hunger Games: Mockingjay Part 2 and Star Wars: the Force Awakens yet Cineworld traditionally under-indexes versus Odeon and Vue on blockbusters and our research suggests this quarter will be no exception. This quarter is as good as it gets for the cinema industry. Next year's film slate is less strong and it could be a 'crowded trade' when the market wakes up to a duller outlook not helped by the distractions of the Olympics and the UEFA European Football Championships next summer.Our analysis round the three autumn blockbusters shows that Odeon is more aggressive on the allocation of screens and Vue is more aggressive on price. Cineworld does not believe in revenue yield optimization. Until it does, we believe it will continue to underperform during industry peaks. We are coming to the view that Cineworld is better at building cinemas in unsophisticated East Europe where competition is weak than optimizing performance from its sophisticated UK portfolio where competition is intense. We estimate Cineworld could be missing out on as much as £2.2m of additional EBITDA per blockbuster in the UK. Assuming a blockbuster/quarter that puts Cineworld’s missed UK opportunity at £8.8m. For 4Q15, with three potential blockbusters, the scale of the missed opportunity may be as much as £6.6m. To put this in context, the UK accounts for c65% of Cineworld EBIT and we are forecasting an H2 EBIT contribution of £44.7m for the UK and £65.4m for group EBIT. It’s a very material lost opportunity for Cineworld. Potential year-end upgrades should not be mistaken for an excellent performance: a rising tide lifts all ships. Our new 535p target price valuation is equivalent to 18.8x PER, 10.0x EV/EBITDA, an 8.0% FCF yield and 3.0% dividend yield for FY15E. The current share price of 594p values the stock on a P/E of 20.9x for FY15E, 18.9x FY16E, an EV/EBITDA of 10.9x falling to 10.0x, a FCF yield of 7.2% rising to 7.9% and dividend yield of 2.7% rising to 2.9% over the same period. It now looks an expensive stock following its re-rating over the last 12 months. Anyone else confused?
30/10/2015
11:58
market sniper1: We are reducing our Cineworld recommendation to SELL from Buy with a new, lowered share price target of 535p (from 620p), implying c10% downside. It’s time to take profits. Cineworld’s share price is up 75% over the last 12 months driven in large part by this year’s fantastic film slate that climaxes this quarter with three blockbusters: Bond Spectre, Hunger Games: Mockingjay Part 2 and Star Wars: the Force Awakens yet Cineworld traditionally under-indexes versus Odeon and Vue on blockbusters and our research suggests this quarter will be no exception. This quarter is as good as it gets for the cinema industry. Next year's film slate is less strong and it could be a 'crowded trade' when the market wakes up to a duller outlook not helped by the distractions of the Olympics and the UEFA European Football Championships next summer.Our analysis round the three autumn blockbusters shows that Odeon is more aggressive on the allocation of screens and Vue is more aggressive on price. Cineworld does not believe in revenue yield optimization. Until it does, we believe it will continue to underperform during industry peaks. We are coming to the view that Cineworld is better at building cinemas in unsophisticated East Europe where competition is weak than optimizing performance from its sophisticated UK portfolio where competition is intense. We estimate Cineworld could be missing out on as much as £2.2m of additional EBITDA per blockbuster in the UK. Assuming a blockbuster/quarter that puts Cineworld’s missed UK opportunity at £8.8m. For 4Q15, with three potential blockbusters, the scale of the missed opportunity may be as much as £6.6m. To put this in context, the UK accounts for c65% of Cineworld EBIT and we are forecasting an H2 EBIT contribution of £44.7m for the UK and £65.4m for group EBIT. It’s a very material lost opportunity for Cineworld. Potential year-end upgrades should not be mistaken for an excellent performance: a rising tide lifts all ships. Our new 535p target price valuation is equivalent to 18.8x PER, 10.0x EV/EBITDA, an 8.0% FCF yield and 3.0% dividend yield for FY15E. The current share price of 594p values the stock on a P/E of 20.9x for FY15E, 18.9x FY16E, an EV/EBITDA of 10.9x falling to 10.0x, a FCF yield of 7.2% rising to 7.9% and dividend yield of 2.7% rising to 2.9% over the same period. It now looks an expensive stock following its re-rating over the last 12 months.
13/8/2015
12:51
mike740: Cineworld Group plc given a Potential Upside of 33.8% Suggested by Citigroup Posted by: Amilia Stone 11th August 2015, updated 13th August 2015 Cineworld Group plc using EPIC code LON:CINE has had its stock rating noted as ‘Initiates/Starts’ with the recommendation being set at ‘BUY’ today by analysts at Citigroup. Cineworld Group plc are listed in the Consumer Services sector within UK Main Market. Citigroup have set their target price at 720 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 33.8% from the opening price of 538 GBX. Cineworld Group plc LON:CINE has a 50 day moving average of 495.38 GBX and a 200 day moving average of 454.10 GBX. The 1 year high share price is 545.42 GBX while the year low stock price is currently 298.4 GBX.
25/1/2015
17:12
cockneyrebel: CINEMA: New 4DX screen coming to Cineworld, Milton Keynes to stimulate all the senses http://www.mkweb.co.uk/CINEMA-New-4DX-screen-coming-Cineworld-Milton/story-25831050-detail/story.html A sneak preview of Swindon's new Cineworld http://www.swindonadvertiser.co.uk/news/11731671.A_sneak_preview_of_Swindon_s_new_Cineworld/ Peel Hunt has great expectations (a great David Lean movie by the way, not to mention the book) for cinema group Cineworld (LON:CINE) in 2015, despite a tough time for the UK box office last year. It has repeated a 'buy' rating on the stock and given a fairly punchy target price price - moving to 440p from 393p. Data released yesterday showed UK and Ireland box office receipts fell by 2.9% to £1.13bn last year. Analyst Nick Batram said: "However, this comes as no surprise in a year of relatively few real blockbusters and the distraction of a World Cup. "Whilst the rerating at Cineworld, on the prospects of a recovery in box office in 2015, has come through quicker than expected, the potential upside to forecasts is significant. "Although there may be some short-term share price consolidation we are happy to retain our 'Buy' recommendation given the potential outperformance over 2015 http://www.proactiveinvestors.co.uk/columns/broker-spotlight/17564/broker-spotlight-cineworld-marshalls-william-hill-dixons-carphone-regency-mines-and-ortac--17564.html
30/1/2014
09:17
enami: So the rights issue shares are now in the sysytem EPIC code LSE:CINN. Should trade at the current CINE share price minus the 230p subscription price. For every 1000 old CINE share you should have now 320 Rights. If you sold say 200 of the rights now it will be enough for the subscription to take up your rights for the remaining 120. CINN = 132.25 vs 360.65 as I type so the rights slightly more valuable than I caculated earlier. TD Direct have not caught up yet so I cannot sell.
Cineworld share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161204 18:26:31